Lipid Metabolism Pathway Analysis Used in research involving fatty acyl-CoA metabolism and related biochemical pathways
doi:10.7759/cureus.70279 Yarizadh H, Shab-Bidar S, Zamani B, Vanani AN, Baharlooi H, Djafarian K
According to primary trials in T2DM, tirzepatide significantly reduces clinical outcomes like body weight, glycated hemoglobin (HbA1c), lipid profiles, and glucose-adjusted glucagon secretion compared to typical glucagon-like peptide1 receptor agonists (GLP1RAs) [1, 2]
The researchers administered an oral glucose tolerance test in which participants consumed 75 grams of glucose, which is roughly the amount of sugar in two cans of sugar-sweetened soda, and had their blood drawn before consuming the glucose (baseline) and at 30, 60, 90, and 120 minutes afterward
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes2025